Spyre Therapeutics(SYRE) - 2018 Q4 - Earnings Call Transcript

Aeglea BioTherapeutics (AGLE) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants David Calusdian - IR, Sharon Merrill Associates Anthony Quinn - Chief Executive Officer Charles York - Chief Financial Officer Jim Wooldridge - Chief Medical Officer Conference Call Participants Josh Schimmer - Evercore ISI Rajvindra Gill - Needham and Company Matthew Cross - H.C. Wainwright Operator Greetings and welcome to the Fourth Quarter 2018 Corporate Update and Earnings Call. And at this time ...